DCRI and SAS Open Data to Researchers
A collaboration between The Duke Clinical Research Institute (DCRI) analytics, business intelligence and data management software and services provider SAS will give researchers access, analytics and data management tools to its database that includes 45 years of cardiovascular patient data collected by the Duke University Health System, including de-identified records for patients; data from more than 100,000 procedures; treatment histories, and more. The information can be used to test clinical hypotheses, develop clinical trial protocols and help researchers assess long-term outcomes and assess time trends. The DCRI and SAS are constructing a data governance plan to ensure the reliability of the data sets and to process requests as efficiently as possible. Researchers can apply for access to the data sets at soar.dcri.org. Read the full release here
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
